Tags: EU | Germany | China | Theater

German Theater Company's Ibsen Play Canceled in China

Wednesday, 12 September 2018 08:38 AM EDT

BERLIN (AP) — A German theater company is ending a tour of China early after a theater canceled two showings of Henrik Ibsen's "An Enemy of the People." German authorities say they regret the cancellation.

Tobias Veit, the director of Berlin's Schaubuehne theater, told German news agency dpa Wednesday two planned performances in the eastern city of Nanjing won't go ahead. The official reason given by the Chinese theater was "technical problems."

The Schaubuehne has been touring with the Ibsen play since 2012. It usually ends with a discussion with the audience, but that was allowed only at the first of three Beijing performances.

German Foreign Ministry spokeswoman Maria Adebahr said Berlin has "taken note with regret" of the cancellation. She said the German embassy informed China's culture ministry of that stance Wednesday.

© Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
A German theater company is ending a tour of China early after a theater canceled two showings of Henrik Ibsen's "An Enemy of the People." German authorities say they regret the cancellation.Tobias Veit, the director of Berlin's Schaubuehne theater, told German news agency...
EU,Germany,China,Theater
132
2018-38-12
Wednesday, 12 September 2018 08:38 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved